Altimmune, Inc. (ALT) vs Phathom Pharmaceuticals, Inc. (PHAT)
Altimmune, Inc. and Phathom Pharmaceuticals, Inc. are both Biotechnology companies. Altimmune, Inc. and Phathom Pharmaceuticals, Inc. are of similar size ($593.3M and $572.8M). Altimmune, Inc. grew revenue faster over the last twelve months: 130.0% against 110.2%. Altimmune, Inc. has the higher net margin (0.00% vs −41.3%) and the lower return on invested capital (−34.3% vs 0.00%). Across the 16 metrics below, Phathom Pharmaceuticals, Inc. leads on 9 and Altimmune, Inc. on 7.
Valuation
Profitability
| Metric | ALT | PHAT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 82.92% | 65.16% |
| Operating margin | 0.00% | (16.96%) | 0.00% |
| Net margin | 0.00% | (41.34%) | 0.00% |
| Free cash flow margin | 0.00% | (15.40%) | 0.00% |
| Return on equity | (28.87%) | 26.42% | (57.72%) |
| Return on assets | (25.58%) | (34.32%) | (49.22%) |
| Return on invested capital | (34.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack